Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Baum

Showing results (31-40 of 143) with videos related to

Pageof 15
Sort By:
Current Opinion in Immunology|September 22, 2012
Genetic modification of lymphocytes by retrovirus-based vectorsJulia D Suerth, Axel Schambach, Christopher Baum
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 3, 2010
Transatlantic consortium spotlights need for changes in gene therapy trialsDavid A Williams, Adrian J Thrasher, Christopher Baum
Human Gene Therapy|January 15, 2013
Biosafety features of lentiviral vectorsAxel Schambach, Daniela Zychlinski, Birgitta Ehrnstroem, et al.
Stem Cells (Dayton, Ohio)|September 8, 2011
Concise review: managing genotoxicity in the therapeutic modification of stem cellsChristopher Baum, Ute Modlich, Gudrun Göhring, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2006
Retrovirus vectors: toward the plentivirus?Christopher Baum, Axel Schambach, Jens Bohne, et al.
The Journal of Clinical Investigation|October 7, 2004
Lenti in red: progress in gene therapy for human hemoglobinopathiesChristof von Kalle, Christopher Baum, David A Williams
Toxicology|February 12, 2002
The cytotoxic effect of mistletoe lectins I, II and III on sensitive and multidrug resistant human colon cancer cell lines in vitroUrsula Valentiner, Uwe Pfüller, Christopher Baum, et al.
Viruses|October 14, 2011
Gammaretroviral vectors: biology, technology and applicationTobias Maetzig, Melanie Galla, Christopher Baum, et al.
Expert Opinion on Biological Therapy|June 10, 2010
Generation and genetic modification of induced pluripotent stem cellsAxel Schambach, Tobias Cantz, Christopher Baum, et al.
Journal of Virology|January 18, 2008
Cellular restriction of retrovirus particle-mediated mRNA transferMelanie Galla, Axel Schambach, Greg J Towers, et al.
Pageof 15

Showing results (31-40 of 143) with videos related to

Sort By:
Pageof 15
Current Opinion in Immunology|September 22, 2012
Genetic modification of lymphocytes by retrovirus-based vectorsJulia D Suerth, Axel Schambach, Christopher Baum
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 3, 2010
Transatlantic consortium spotlights need for changes in gene therapy trialsDavid A Williams, Adrian J Thrasher, Christopher Baum
Human Gene Therapy|January 15, 2013
Biosafety features of lentiviral vectorsAxel Schambach, Daniela Zychlinski, Birgitta Ehrnstroem, et al.
Stem Cells (Dayton, Ohio)|September 8, 2011
Concise review: managing genotoxicity in the therapeutic modification of stem cellsChristopher Baum, Ute Modlich, Gudrun Göhring, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 25, 2006
Retrovirus vectors: toward the plentivirus?Christopher Baum, Axel Schambach, Jens Bohne, et al.
The Journal of Clinical Investigation|October 7, 2004
Lenti in red: progress in gene therapy for human hemoglobinopathiesChristof von Kalle, Christopher Baum, David A Williams
Toxicology|February 12, 2002
The cytotoxic effect of mistletoe lectins I, II and III on sensitive and multidrug resistant human colon cancer cell lines in vitroUrsula Valentiner, Uwe Pfüller, Christopher Baum, et al.
Viruses|October 14, 2011
Gammaretroviral vectors: biology, technology and applicationTobias Maetzig, Melanie Galla, Christopher Baum, et al.
Expert Opinion on Biological Therapy|June 10, 2010
Generation and genetic modification of induced pluripotent stem cellsAxel Schambach, Tobias Cantz, Christopher Baum, et al.
Journal of Virology|January 18, 2008
Cellular restriction of retrovirus particle-mediated mRNA transferMelanie Galla, Axel Schambach, Greg J Towers, et al.
Pageof 15